publication venue for
- Chemoradiation, surgery and adjuvant chemotherapy versus induction chemotherapy followed by chemoradiation and surgery: Long-term results of the Spanish GCR-3 phase II randomized trial. 1722-1728. 2015
- Docetaxel plus oxaliplatin with or without fluorouracil or capecitabine in metastatic or locally recurrent gastric cancer: a randomized phase II study. 149-156. 2015
- Randomized phase III study of 3-weekly versus weekly docetaxel in pretreated advanced non-small cell lung cancer: a spanish lung cancer group trial. 467-472. 2006
- Phase II trial of the novel taxane BMS-184476 as second-line in non-small-cell lung cancer. 597-601. 2005
- Randomized phase III study of 3-weekly versus weekly docetaxel in pretreated advanced non-small cell lung cancer: a spanish lung cancer group trial.. 1-6. 2005
- Phase I/II trial of Irinotecan plus weekly 48-h continuous infusion of high-dose 5-fluorouracil (TTD regimen) as first-line chemotherapy of advanced colorectal cancer. 559-567. 2004
- FAC (fluorouracil, doxorubicin, cyclophosphamide) versus CMF (cyclophosphamide, methotrexate, fluorouracil) as adjuvant chemotherapy for operable breast cancer: A study by the GEICAM group.. 833-842. 2003
- Sequential dose-dense paclitaxel followed by topotecan in untreated extensive-stage small-cell lung cancer (SCLC): A Spanish Lung Cancer Group phase II study. 1549-1554. 2003